All articles tagged with #baylor college of medicine
A new non-hormonal male contraceptive, CDD-2807, has shown promising results in mice, effectively reducing sperm activity and being reversible without significant side effects. Researchers at Baylor College of Medicine are optimistic about its potential and plan to test it in non-human primates.
Researchers at Baylor College of Medicine have made significant progress towards developing a male birth control pill by identifying a compound that inhibits a protein crucial for male fertility. The compound, which has shown temporary contraceptive effects in mice, will need further testing on non-human primates before human trials can begin. This development represents a potential breakthrough in male contraception, which has faced numerous challenges over the years.
Scientists at Baylor College of Medicine have developed a new technology that allows for precise control of gene expression in gene therapy, akin to flipping a light switch. This method utilizes small, FDA-approved substances to regulate genes without triggering harmful immune responses, unlike previous techniques. This advancement could be crucial in ensuring therapeutic gene levels remain within a safe and effective range.
Researchers from Baylor College of Medicine have discovered that deleting the SRC-3 gene from animal immunity cells leads to the death of tumors and provides long-lasting protection from cancer. SRC-3 is involved in promoting tumor growth in all types of cancers that affect humans and is expressed in Tregs, immune cells that prevent autoimmune disorders by suppressing our body’s immune response.